Arthritis Foundation logo
Welcome!
Log In  |  Create Profile
Search:
advanced search                                    Español
Home Donate Store Resources Communities Events and Programs Conditions and Treatments Advocacy Research
 
Find Your Local Office
Become A Member
Questions and Answers
Assess Your Joint Health
Disease Center
Learn About Arthritis
Drug Guide
Supplement Guide
Diet and Nutrition
Ask Dr. Klippel
Juvenile Arthritis
Joint Surgery Center
Pain Center
Alternative Therapies
Guide to Lab Tests
Glossary of Health Professionals
Exercise and Arthritis
Your Feet and Arthritis
51 Ways to Be Good to Your Joints
Message Boards
RA Connect
 
 
Osteoarthritis
Overview
Symptoms
Who Gets It?
Causes
Diagnosis
Treatment

Science & Research
Epidemiology
Pathology
Classification Guidelines
Alternative &
Experimental Therapies
Factors Leading to
Secondary OA
Quality
Measurements
Do You Know?
Learn About Arthritis
Resources for
People with OA
Información en Español

Alternative and Experimental Therapies
reprinted from Primer on the Rheumatic Diseases, edition 12

An estimated 23 percent of people with osteoarthritis (OA) regularly use alternative and complementary therapies (9). Most patients using unconventional remedies are willing to discuss these therapies with their physician when asked (9). Understanding these alternative therapies can allow the physician to  educate the patient with the information available about their use in OA and possible risks of treatment. These discussions can help patients use judgement when considering  alternative treatments and avoid potentially harmful interventions.

Glucosamine and Chrondroitin
Glucosamine and chrondroitin preparations are used commonly by people with OA and are widely advocated in lay publications. Multiple sources distribute these compounds. Because they are not classified as medications, but rather regulated as nutritional supplements,  the quality and constitution of the different preparations varies. Fortunately, only minimal adverse events with glucosamine and chondroitin sulfate have been described.

Although several studies of these therapies have been published, the quality of these investigations is not optimal. Limitations in these investigations include methodologic weaknesses, proprietary sponsorship, and possible publication bias (10). Despite these limitations, there is a possibility that these compounds may improve OA symptoms and even reduce the radiographic progression of OA.  Large-scale, ongoing investigations of these agents may answer important questions.

Cartilage Repair and Transplantation
Extensive work has attempted to promote cartilage repair and restore normal cartilage tissue (11). Experimental procedures used to promote cartilage repair include penetration of the subchondral bone, osteotomy, joint distraction, soft-tissue graft of her periosteum or perichrondrium, cell transplantation, and use of growth factors. Unfortunately, these procedures generally are not successful in promoting cartilage repair. Results of early clinical experience with cartilage transplantation of autografts and allografts suggest that these procedures may benefit selected patient populations with focal cartilage defects. Currently, these procedures are not sufficiently successful for general application in people with OA.

EMAIL THIS PAGE
 


Home | Privacy Policy | About Us | Contact Us | Employment | Media News Room | Sponsors | Become a Member | Español | Terms of Service | Site Map
© Copyright 2007, Arthritis Foundation. All Rights Reserved.